Tetramethylammonium hydroxide poisoning

被引:64
作者
Lin, Chun-Chi
Yang, Chen-Chang [1 ,2 ]
Ger, Jiin [1 ]
Deng, Jou-Fang [1 ]
Hung, Dong-Zong [3 ,4 ]
机构
[1] Taipei Vet Gen Hosp, Dept Med, Div Clin Toxicol, Taipei 112, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Dept Environm & Occupat Med, Taipei 112, Taiwan
[3] China Med Univ, Grad Inst Drug Safety, Taichung, Taiwan
[4] China Med Univ Hosp, Div Clin Toxicol, Taichung, Taiwan
关键词
SKIN;
D O I
10.3109/15563651003627777
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Introduction. Tetramethylammonium hydroxide (TMAH) is widely used as a developer or etchant in semiconductor and photoelectric industries. In addition to alkalinity-related chemical burn, dermal exposure to TMAH may also result in respiratory failure and/or sudden death. The latter toxic effect has been of great concern in Taiwan after the occurrence of three fatalities in recent years. To better understand the toxicity following dermal exposure to TMAH, we analyzed all cases with TMAH exposure reported to the Taiwan Poison Control Center (PCC-Taiwan). Case reports. In total, there were 13 cases of such exposure, including three patients who died after being exposed to 25% TMAH. A worker also developed severe effects manifesting muscle weakness, dyspnea, hyperglycemia, and chemical burn (28% of total body surface area) shortly after an accidental exposure to 2.38% TMAH. He received endotracheal intubation with assisted ventilation for 2 days and survived. Conclusion. Skin corrosive injury related to the alkalinity of TMAH and the ganglionic toxicity of tetramethylammonium ion might contribute to the clinical manifestations that occurred after dermal TMAH exposure. Thorough skin decontamination followed by prompt respiratory support should be the mainstay in the management of dermal TMAH exposure. Preventive strategies are warranted as well to decrease future occupational TMAH exposures.</.
引用
收藏
页码:213 / 217
页数:5
相关论文
共 19 条
[1]  
Ackermann D, 1923, Z BIOL, V78, P113
[2]   TETRAMINE - OCCURRENCE IN MARINE ORGANISMS AND PHARMACOLOGY [J].
ANTHONI, U ;
BOHLIN, L ;
LARSEN, C ;
NIELSEN, P ;
NIELSEN, NH ;
CHRISTOPHERSEN, C .
TOXICON, 1989, 27 (07) :707-716
[3]   SALIVARY POISON OF A MARINE GASTROPOD, NEPTUNEA-ARTHRITICA BERNARDI, AND THE SEASONAL VARIATION OF ITS TOXICITY [J].
ASANO, M ;
ITOH, M .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1960, 90 (03) :674-688
[4]  
BAKRY NM, 1982, MOL PHARMACOL, V22, P63
[5]  
GEBBER GL, 1966, J PHARMACOL EXP THER, V152, P18
[6]   THE TOXIC PRINCIPLE OF COURBONIA-VIRGATA - ITS ISOLATION AND IDENTIFICATION AS A TETRAMETHYLAMMONIUM SALT [J].
HENRY, AJ .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1948, 3 (03) :187-188
[7]  
HO CK, 2007, 2007 INT C CHEM DIS
[8]   TETRAMETHYLAMMONIUM IS A MUSCARINIC AGONIST IN RAT-HEART [J].
KENNEDY, RH ;
WYETH, RP ;
GERNER, P ;
LIU, S ;
FONTENOT, HJ ;
SEIFEN, E .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1995, 268 (06) :C1414-C1417
[9]   Agonist and blocking actions of choline and tetramethylammonium on human muscle acetylcholine receptors [J].
Lape, Remigijus ;
Krashia, Paraskevi ;
Colquhoun, David ;
Sivilotti, Lucia G. .
JOURNAL OF PHYSIOLOGY-LONDON, 2009, 587 (21) :5045-5072
[10]   STRUCTURE-PHARMACOKINETICS RELATIONSHIP OF QUATERNARY AMMONIUM-COMPOUNDS - ELIMINATION AND DISTRIBUTION CHARACTERISTICS [J].
NEEF, C ;
OOSTING, R ;
MEIJER, DKF .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1984, 328 (02) :103-110